Related Experiment Video
Updated: Aug 11, 2026
15:42
Xenotransplantation of Human Stem Cells into the Chicken Embryo
Published on: July 11, 2010
Xenotransplantation: perspectives from The Netherlands
1Health Council of The Netherlands, Den Haag, The Netherlands. e.van.rongen@gr.nl
Annals of the New York Academy of Sciences
|February 3, 1999
Summary
Xenotransplantation is ethically acceptable but not yet clinically viable due to rejection and safety concerns. Genetically engineered pigs are preferred over primates, but legal frameworks require updates for safe clinical application.
Area of Science:
- Biomedical Ethics
- Transplantation Medicine
- Regulatory Science
Background:
- Xenotransplantation, using animal organs for human recipients, faces ethical approval but practical hurdles.
- Concerns include immune rejection and the potential transmission of zoonotic diseases.
- Current regulations struggle to address the unique challenges of genetically engineered source animals.
Purpose of the Study:
- To assess the ethical acceptability and clinical readiness of xenotransplantation.
- To identify key barriers to clinical application, focusing on safety and regulatory aspects.
- To propose necessary legal and regulatory adjustments for the responsible advancement of xenotransplantation.
Main Methods:
- Review of the Health Council of the Netherlands' report on xenotransplantation.
- Analysis of ethical considerations from human and animal perspectives.
- Evaluation of current legal and regulatory frameworks in the Netherlands and Europe.
Main Results:
- Xenotransplantation is deemed ethically acceptable.
- Clinical application is not yet recommended due to rejection issues and pathogen transmission risks.
- Genetically engineered pigs are the preferred source animals, while non-human primates are unsuitable.
- Existing Dutch and European regulations are inadequate for genetically engineered animals and xenotransplants.
Conclusions:
- Further research is essential to overcome technical and safety challenges.
- Legal and regulatory frameworks require significant revision, including a national law for biologicals.
- International agreements are needed to manage xenotransplantation, potentially by classifying xenotransplants as medicines for regulatory oversight.
Related Concept Videos
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...